Current Environment: Production

Medical Services

Specialties

Programs & Services

Languages

  • English

Education

Medical School

Tufts University School of Medicine

1999, Boston, MA

Residency

Children's Memorial Hospital

2002, Chicago, IL

Fellowship

Pediatric Gastroenterology

Boston Children's Hospital

2005, Boston, MA

Fellowship

Hepatology

Boston Children's Hospital

2006, Boston, MA

Certifications

  • American Board of Pediatrics (Gastroenterology)
  • American Board of Pediatrics (Transplant Hepatology)

Professional History

Dr. Elisofon serves as the Medical Director of the Liver Transplant Program.  His specialties include childhood liver and biliary tract disease in addition to liver transplantation. Dr. Elisofon is board certified in Pediatric Gastroenterology and Pediatric Transplant Hepatology.

Dr. Elisofon is an active participant in SPLIT (Studies of Pediatric Liver Transplantation), a multi-center registry for Pediatric Liver Transplant. He has been a past committee member of the UNOS Pediatric Transplant Committee. 

Locally, Dr. Elisofon serves on the Medical Advisory Committee for the American Liver Foundation, New England Division.

Media

Caregiver Profile

Meet Dr. Scott Elisofon

Publications

  1. Postvaccination Immunogenicity Among Pediatric Solid Organ Transplant Recipients. JAMA Pediatr. 2025 Apr 01; 179(4):467-471. View Abstract

  2. Cytomegalovirus prophylaxis in pediatric liver transplantation: A comparison of strategies across the Society of Pediatric Liver Transplantation (SPLIT) consortium. Am J Transplant. 2025 May; 25(5):1098-1106. View Abstract

  3. Early Graft Loss With Suspected Seventh-Day Syndrome Following Pediatric Liver Transplantation. Pediatr Transplant. 2024 Aug; 28(5):e14818. View Abstract

  4. Clinical and immunophenotype correlating with response to immunotherapy in paediatric patients with primary liver carcinoma. A case series. EBioMedicine. 2024 Jun; 104:105147. View Abstract

  5. Safety and Immunogenicity of Live Viral Vaccines in a Multicenter Cohort of Pediatric Transplant Recipients. JAMA Netw Open. 2023 10 02; 6(10):e2337602. View Abstract

  6. Fecal Microbiota Transplant in Pediatric Solid Organ Transplant Recipients. Transplantation. 2023 09 01; 107(9):2073-2077. View Abstract

  7. A quality improvement intervention to decrease the decline in renal function in pediatric liver transplant recipients. Pediatr Transplant. 2023 06; 27(4):e14506. View Abstract

  8. Predictors of survival following liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma: Experience from the Society of Pediatric Liver Transplantation (SPLIT). Am J Transplant. 2022 05; 22(5):1396-1408. View Abstract

  9. Severe Acute Respiratory Syndrome Coronavirus-2 Infection in Children With Liver Transplant and Native Liver Disease: An International Observational Registry Study. J Pediatr Gastroenterol Nutr. 2021 06 01; 72(6):807-814. View Abstract

  10. Transient elastography assessment of liver allograft fibrosis in pediatric transplant recipients. Pediatr Transplant. 2020 09; 24(6):e13736. View Abstract

  11. Progressive multifocal leukoencephalopathy presenting with acute sensorineural hearing loss in an intestinal transplant recipient. Transpl Infect Dis. 2020 Aug; 22(4):e13304. View Abstract

  12. The re-occurrence of cardiomyopathy in propionic acidemia after liver transplantation. JIMD Rep. 2020 Jul; 54(1):3-8. View Abstract

  13. Biliary Atresia: Biliary-Enteric Drainage or Primary Liver Transplant? Hepatology. 2020 02; 71(2):751-752. View Abstract

  14. Society of pediatric liver transplantation: Current registry status 2011-2018. Pediatr Transplant. 2020 02; 24(1):e13605. View Abstract

  15. Reply to letter to the editor. J Pediatr Surg. 2020 01; 55(1):202. View Abstract

  16. Pediatric post-transplant hepatic kaposi sarcoma due to donor-derived human herpesvirus 8. Pediatr Transplant. 2019 05; 23(3):e13384. View Abstract

  17. Predictors of Need for Liver Transplantation in Children Undergoing Hepatoportoenterostomy for Biliary Atresia. J Pediatr Surg. 2019 Jun; 54(6):1127-1131. View Abstract

  18. Long-term outcomes of liver transplantation for hepatoblastoma: A single-center 14-year experience. Pediatr Transplant. 2018 Jun 11; e13250. View Abstract

  19. Bilateral native nephrectomy to reduce oxalate stores in children at the time of combined liver-kidney transplantation for primary hyperoxaluria type 1. Pediatr Nephrol. 2018 05; 33(5):881-887. View Abstract

  20. Outcomes after discontinuation of routine use of transanastomotic biliary stents in pediatric liver transplantation at a single site. Pediatr Transplant. 2016 Aug; 20(5):647-51. View Abstract

  21. Hematopoietic stem cell transplantation outcomes for 11 patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol. 2016 09; 138(3):852-859.e3. View Abstract

  22. Treatment and outcomes of immune cytopenias following solid organ transplant in children. Pediatr Blood Cancer. 2015 02; 62(2):214-218. View Abstract

  23. Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial. Hepatology. 2013 Apr; 57(4):1542-9. View Abstract

  24. Health status of patients with Alagille syndrome. J Pediatr Gastroenterol Nutr. 2010 Dec; 51(6):759-65. View Abstract

  25. Hepatic failure in a rapidly involuting congenital hemangioma of the liver: failure of embolotherapy. Pediatr Radiol. 2009 Oct; 39(10):1118-23. View Abstract

  26. Hepatitis B and C in children: current treatment and future strategies. Clin Liver Dis. 2006 Feb; 10(1):133-48, vii. View Abstract
BESbswy